⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6498246 | 0.78 | — | — | |
| SCHEMBL608314 | 0.76 | — | — | |
| SCHEMBL27705444 | 0.74 | — | — | |
| SCHEMBL18734285 | 0.74 | — | — | |
| SCHEMBL12229581 | 0.73 | HDAC1 (0.37) | — | |
| SCHEMBL27887198 | 0.73 | — | — | |
| SCHEMBL3910931 | 0.73 | KDM5A (0.41) | — | |
| SCHEMBL2926647 | 0.72 | CYP2E1 (0.38) | — | |
| SCHEMBL20306728 | 0.71 | — | — | |
| SCHEMBL16704705 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 530 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119570222-A | Degradable composite film paper material and preparation method thereof | 广东道科新材料科技有限公司 | 2025-03-07 | — | — | CN | claimed |
| US-11668708-B2 | Method for reducing measurement error in latex agglutination immunoassay | SEKISUI MEDICAL CO., LTD. (JP) | 2023-06-06 | — | — | US | claimed |
| CN-112635804-A | Alkaline anion exchange membrane for fuel cell and preparation method thereof | 安徽知凸凸科技服务有限公司 | 2021-04-09 | — | — | CN | claimed |
| CN-107667097-B | Separation of enantiomers of 3-ethylbicyclo [3.2.0] hept-3-en-6-one | 诺瓦色生物公司 | 2021-02-12 | — | — | CN | claimed |
| EP-3303308-B1 | SEPARATION OF ENANTIOMERS OF 3-ETHYLBICYCLO[3.2.0]HEPT-3-EN-6-ONE | NOVASSAY SA (CH) | 2019-10-09 | — | — | EP | claimed |
| US-10150723-B2 | Separation of enantiomers of 3-ethylbicyclo[3.2.0]hept-3-en-6-one | NOVASSAY S.A. (CH) | 2018-12-11 | — | — | US | claimed |
| US-20180134643-A1 | SEPARATION OF ENANTIOMERS OF 3-ETHYLBICYCLO[3.2.0]HEPT-3-EN-6-ONE | NOVASSAY S.A. (CH) | 2018-05-17 | — | — | US | claimed |
| EP-3303308-A1 | SEPARATION OF ENANTIOMERS OF 3-ETHYLBICYCLO[3.2.0]HEPT-3-EN-6-ONE | Novassay SA (CH) | 2018-04-11 | — | — | EP | claimed |
| WO-2016146299-A1 | SEPARATION OF ENANTIOMERS OF 3-ETHYLBICYCLO[3.2.0]HEPT-3-EN-6-ONE | NOVASSAY SA (CH) | 2016-09-22 | — | — | WO | claimed |
| EP-1817036-B1 | MODULATORS OF MUSCARINIC RECEPTORS | VERTEX PHARMA (US) | 2012-07-04 | — | — | EP | claimed |
| EP-4724437-A1 | METHODS OF TREATING INFLAMMATORY DISEASES | Interline Therapeutics, Inc. (US) | 2026-04-15 | — | — | EP | disclosed |
| US-20260091026-A1 | METHODS OF TREATING INFLAMMATORY DISEASES | INTERLINE THERAPEUTICS INC (US) | 2026-04-02 | — | — | US | disclosed |
| US-12465643-B2 | Ras inhibitors | Revolution Medicines, Inc. (US) | 2025-11-11 | — | — | US | disclosed |
| US-20250319187-A1 | RAS INHIBITORS | REVOLUTION MEDICINES INC (US) | 2025-10-16 | — | — | US | disclosed |
| US-20250304597-A1 | COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2025-10-02 | — | — | US | disclosed |
| US-5068237-A | Substituted furans and derivatives thereof acting at muscarinic receptors | WARNER-LAMBERT COMPANY (US) | 1991-11-26 | — | — | US | disclosed |
| CN-1012365-B | 2- (N-substituted guanidino) -4-heteroaryl thiazole antiulcer agent and its preparation method | PFIZER (US) | 1991-04-17 | — | — | CN | disclosed |
| US-4814343-A | ANTIISCHEMIC | U C B, S.A. (BE) | 1989-03-21 | — | — | US | disclosed |
| EP-0269599-A2 | Substituted 1H-imidazoles | U C B, S.A. (BE) | 1988-06-01 | — | — | EP | disclosed |
| CN-85103265-A | The method of preparation 2-(guanidine radicals that N-replaces)-4-heteroaryl thiazole anti ulcer agent | — | 1986-12-10 | — | — | CN | disclosed |